切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - KDM - Na /K /Cl- Symporters (NKCCs) - Inward Rectifier Potassium (Kir) Channels - CSF-1R

13件产品中的 1-10

页面
每页
清除全部
  1. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: 酪氨酸激酶抑制剂(TKI)
      ≥10.62 mg/mL
      ≥168.2 mg/mL
  2. TC-E 5002
    B4930 TC-E 5002
    Target: KDM
    Summary: 选择性组蛋白去甲基化酶KDM2/7亚家族抑制剂
      Soluble in DMSO
  3. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R激酶抑制剂
      ≥19.9 mg/mL
      insoluble in H2O
  4. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  5. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  6. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. Furosemide
    A8435 Furosemide
    中文名: 呋塞米
    Target: Na /K /Cl- Symporters (NKCCs)|GABAA Receptors
    Summary: GABAA受体拮抗剂
      ≥14.9 mg/mL
      insoluble in H2O
  10. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS激酶/CSF-1R抑制剂
      ≥36.6 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页